CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau

Abstract Background Delirium and dementia share symptoms of cognitive dysfunctions, and mechanisms of neuroinflammation appear involved in both conditions. Triggering receptor expressed on myeloid cells 2 (TREM2) is linked to dementia and neurodegenerative disease. It encodes expression of an innate...

Full description

Bibliographic Details
Main Authors: Kristi Henjum, Else Quist-Paulsen, Henrik Zetterberg, Kaj Blennow, Lars N. G. Nilsson, Leiv Otto Watne
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-018-1331-1
_version_ 1818321732318003200
author Kristi Henjum
Else Quist-Paulsen
Henrik Zetterberg
Kaj Blennow
Lars N. G. Nilsson
Leiv Otto Watne
author_facet Kristi Henjum
Else Quist-Paulsen
Henrik Zetterberg
Kaj Blennow
Lars N. G. Nilsson
Leiv Otto Watne
author_sort Kristi Henjum
collection DOAJ
description Abstract Background Delirium and dementia share symptoms of cognitive dysfunctions, and mechanisms of neuroinflammation appear involved in both conditions. Triggering receptor expressed on myeloid cells 2 (TREM2) is linked to dementia and neurodegenerative disease. It encodes expression of an innate immune receptor in the brain expressed by microglia. The level of the soluble fragment of TREM2 (sTREM2) is reported to increase in the cerebrospinal fluid (CSF) already in prodromal and asymptomatic Alzheimer’s disease. Methods We analyzed the level of CSF sTREM2 in relation to delirium and dementia. The study included patients with or without pre-existing dementia who underwent acute hip fracture surgery (n = 120), and some of the patients developed delirium (n = 65). A medical delirium cohort (n = 26) was also examined. ELISA was used to determine the level of sTREM2 in CSF. Results Delirium was associated with a higher level of CSF sTREM2 only among those without pre-existing dementia (p = 0.046, n = 15, n = 44), particularly among patients developing delirium after CSF sampling (p = 0.02, n = 7, n = 44). Between patients with dementia, there was no group difference, but the CSF sTREM2 level increased with waiting time for surgery (r S = 0.39, p = 0.002, n = 60) and correlated well with the CSF Alzheimer’s disease biomarkers, Aβ42, and t-tau/p-tau (r S = 0.40, p = 0.002, r S = 0.46, p < 0.001/ r S = 0.49, p < 0.001, n = 60). Among patients with dementia, the level of Aβ38 and Aβ40 also correlated positively with sTREM2 in CSF (Aβ38MSD r S = 0.44, p = 0.001; Aβ40MSD r S = 0.48, p < 0.001; Aβ42MSD r S = 0.43, p < 0.001, n = 60). Conclusion The findings reinforce the involvement of neuroinflammation in delirium, yet with separate responses in patients with or without pre-existing dementia. Our findings support the concept of primed microglia in neurodegenerative disease and central immune activation after a peripheral trauma in such patients. A CSF biomarker panel of neuroinflammation might be valuable to prevent delirium by identifying patients at risk.
first_indexed 2024-12-13T10:45:35Z
format Article
id doaj.art-6fe10ad4cfe64a93b3cbbfa0132e684f
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-13T10:45:35Z
publishDate 2018-11-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-6fe10ad4cfe64a93b3cbbfa0132e684f2022-12-21T23:50:13ZengBMCJournal of Neuroinflammation1742-20942018-11-0115111510.1186/s12974-018-1331-1CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tauKristi Henjum0Else Quist-Paulsen1Henrik Zetterberg2Kaj Blennow3Lars N. G. Nilsson4Leiv Otto Watne5Department of Pharmacology, Institute of Clinical Medicine, University of Oslo and Oslo University HospitalDepartment of Infectious Diseases, Oslo University Hospital, Ullevaal HospitalDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of GothenburgDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of GothenburgDepartment of Pharmacology, Institute of Clinical Medicine, University of Oslo and Oslo University HospitalOslo Delirium Research Group, Department of Geriatric Medicine, Oslo University HospitalAbstract Background Delirium and dementia share symptoms of cognitive dysfunctions, and mechanisms of neuroinflammation appear involved in both conditions. Triggering receptor expressed on myeloid cells 2 (TREM2) is linked to dementia and neurodegenerative disease. It encodes expression of an innate immune receptor in the brain expressed by microglia. The level of the soluble fragment of TREM2 (sTREM2) is reported to increase in the cerebrospinal fluid (CSF) already in prodromal and asymptomatic Alzheimer’s disease. Methods We analyzed the level of CSF sTREM2 in relation to delirium and dementia. The study included patients with or without pre-existing dementia who underwent acute hip fracture surgery (n = 120), and some of the patients developed delirium (n = 65). A medical delirium cohort (n = 26) was also examined. ELISA was used to determine the level of sTREM2 in CSF. Results Delirium was associated with a higher level of CSF sTREM2 only among those without pre-existing dementia (p = 0.046, n = 15, n = 44), particularly among patients developing delirium after CSF sampling (p = 0.02, n = 7, n = 44). Between patients with dementia, there was no group difference, but the CSF sTREM2 level increased with waiting time for surgery (r S = 0.39, p = 0.002, n = 60) and correlated well with the CSF Alzheimer’s disease biomarkers, Aβ42, and t-tau/p-tau (r S = 0.40, p = 0.002, r S = 0.46, p < 0.001/ r S = 0.49, p < 0.001, n = 60). Among patients with dementia, the level of Aβ38 and Aβ40 also correlated positively with sTREM2 in CSF (Aβ38MSD r S = 0.44, p = 0.001; Aβ40MSD r S = 0.48, p < 0.001; Aβ42MSD r S = 0.43, p < 0.001, n = 60). Conclusion The findings reinforce the involvement of neuroinflammation in delirium, yet with separate responses in patients with or without pre-existing dementia. Our findings support the concept of primed microglia in neurodegenerative disease and central immune activation after a peripheral trauma in such patients. A CSF biomarker panel of neuroinflammation might be valuable to prevent delirium by identifying patients at risk.http://link.springer.com/article/10.1186/s12974-018-1331-1DeliriumDementiaAlzheimer’s diseaseCSF biomarkersSoluble TREM2
spellingShingle Kristi Henjum
Else Quist-Paulsen
Henrik Zetterberg
Kaj Blennow
Lars N. G. Nilsson
Leiv Otto Watne
CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
Journal of Neuroinflammation
Delirium
Dementia
Alzheimer’s disease
CSF biomarkers
Soluble TREM2
title CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
title_full CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
title_fullStr CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
title_full_unstemmed CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
title_short CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
title_sort csf strem2 in delirium relation to alzheimer s disease csf biomarkers aβ42 t tau and p tau
topic Delirium
Dementia
Alzheimer’s disease
CSF biomarkers
Soluble TREM2
url http://link.springer.com/article/10.1186/s12974-018-1331-1
work_keys_str_mv AT kristihenjum csfstrem2indeliriumrelationtoalzheimersdiseasecsfbiomarkersab42ttauandptau
AT elsequistpaulsen csfstrem2indeliriumrelationtoalzheimersdiseasecsfbiomarkersab42ttauandptau
AT henrikzetterberg csfstrem2indeliriumrelationtoalzheimersdiseasecsfbiomarkersab42ttauandptau
AT kajblennow csfstrem2indeliriumrelationtoalzheimersdiseasecsfbiomarkersab42ttauandptau
AT larsngnilsson csfstrem2indeliriumrelationtoalzheimersdiseasecsfbiomarkersab42ttauandptau
AT leivottowatne csfstrem2indeliriumrelationtoalzheimersdiseasecsfbiomarkersab42ttauandptau